Many cancer doctors have cut back on their use of Amgen's anemia drug Epogen–also sold as Procrit by Johnson & Johnson–because of safety questions that arose over the past few years. But as <em>The Wall Street Journal </em>reports, one Florida doctors' group still administers the drug in quantity, accounting for one-sixth of related Medicare charges in 2012.
written on 23.06.2014
Some cancer docs still bill heavily for Amgen's Epogen despite safety questions
